DRUG · Unmapped registry intervention
Zinc Acexamate
Find medicine records ·
Find other trials using this name
Clinical trial
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
NCT06434753
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedZinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
Zinc AcexamateDRUG
Sponsors & collaborators
Hospital General Universitario Gregorio Marañoncollaborator
Hospital Vall d'Hebroncollaborator
Puerta de Hierro University Hospitalcollaborator
Hospital Clinic of Barcelonacollaborator
Hospital Universitario Central de Asturiascollaborator
Complejo Hospitalario de Toledocollaborator
Germans Trias i Pujol Hospitalcollaborator
Hospital Universitario Marqués de Valdecillacollaborator
Hospital Miguel Servetcollaborator
Parc Taulí Hospital Universitaricollaborator
Hospital de la Santa creu i Sant Pau - Barcelonacollaborator
Hospital Universitari de Bellvitgecollaborator
Hospital del Marcollaborator
University Hospital of Girona Dr. Josep Truetacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06434753 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.